Non-β-hemolytic Streptococcal Bacteremia in Patients With Heart Valve Prosthesis-Is It Always Infective Endocarditis?

Fanni Toivonen1, Torgny Sunnerhagen1,2, Johannes Lundin1

  • 1Division of Infection Medicine, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden.

Insights

Patients with heart valve prostheses and non-β-hemolytic streptococcal bacteremia face a high risk of infective endocarditis. Shorter antibiotic courses may lead to relapse, highlighting the need for thorough investigation and appropriate treatment duration.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Non-β-hemolytic streptococci are common causes of infective endocarditis (IE).
  • Patients with heart valve prostheses (HVP) are at increased risk for IE.
  • Non-β-hemolytic streptococcal bacteremia (NBHSB) in HVP patients warrants careful evaluation.

Purpose of the Study:

  • To determine the risk of IE in patients with HVP and NBHSB.
  • To investigate the rate of NBHSB relapse based on antibiotic treatment duration.

Main Methods:

  • Retrospective population-based study of adults with HVP and NBHSB (2015-2018).
  • Data collected from medical records using a predefined protocol.
  • IE diagnosis based on European Society of Cardiology 2015 criteria.

Main Results:

  • 110 NBHSB episodes in 89 HVP patients were analyzed.
  • Definite IE occurred in 36% of episodes; possible IE in 64%.
  • Seven NBHSB relapses were observed, primarily in patients with possible IE and short antibiotic courses (<14 days).

Conclusions:

  • Patients with NBHSB and HVP have a significant risk for IE.
  • Thorough investigation and appropriate antibiotic treatment duration are crucial for managing these patients.
  • Short-course antibiotic therapy may be associated with an increased risk of NBHSB relapse.
Abstract

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
3.9K
Heart Valves01:17

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
3.8K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.3K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
30.7K